Are you actively seeking funding for your startup’s next phase of growth?

We are currently on the lookout for innovative tech startups to present! Showcase your company in front of engaged attendees and gain access to subject matter experts ready to contribute to your success.


i-Lumen Scientific – Judge’s Choice Award Recipient

Okulovision – People’s Choice Award Recipient

2024 Presenting Companies


Eyetronic provides non-invasive stimulation for neuropathies of the optic nerve.



EYETRONIC® is a non-invasive optic nerve stimulation therapy treating glaucoma. Glaucoma, a progressive disease of the optic nerve, is the leading cause for irreversible blindness affecting more than 80 million patients.

Current Standard-of-Care is focused on elevated intraocular pressure (IOP) that has not shown to stop progression of vision loss.

EYETRONIC® targets the underlying neuropathy of the optic nerve, reactivating metabolism. Peer-reviewed published data confirm a halt in vision loss at 12-month in 64%-78% of eyes, depending on the type of glaucoma. The therapy is CE certified. In more than 8,000 sessions not a single serious adverse event (SAE) was observed.

ForwardVue has developed a novel therapeutic for the treatment of chronic retinal disease.
ForwardVue Pharma

ForwardVue Pharma is a physician-founded ophthalmic start-up developing a potent, highly differentiated solution for the treatment of chronic retinal disease, the leading cause of blindness and vision loss worldwide. We have a novel, small molecule compound with a unique mechanism of action that will deliver a safe and highly potent response to neovascular age-related macular degeneration. When complexed with certain polymers, we can deliver this compound in a durable, bioresorbable implant via standard intravitreal injection in a simple office-based procedure. We’ve demonstrated significantly improved potency vs. standard of care in at least two different validated clinicals models of neovascular retinopathy.

Changing the Game in Intraoperative Visualization for MIGS and Beyond


Synopic is an early stage startup changing the game in intraoperative visualization for minimally invasive procedures. Synopic is solving the problem of poor surgical vision, inefficiencies, and lack of real-time data during procedures with their ultracompact, depth-enabled imaging system, initially focusing on ophthalmology and glaucoma which affects 80M people globally and is the leading cause of irreversible blindness. Synopic’s technology has the capability to expand to and be applied in endoscopy and other minimally invasive procedures.

Present on the Main Stage

The Forum will host our annual Capital & Growth Presentations. One of the ways the Forum highlights innovation is through the presenting companies showcasing their cutting-edge ideas and products during the three-minute pitch sessions.

    Gain unparalleled exposure among industry leaders, investors, and healthcare professionals.
    Connect with potential collaborators, investors, and key decision-makers in the cardiovascular tech space.
    Demonstrate how your company is shaping the future of cardiovascular health through cutting-edge technologies.

How to Apply:

Complete the form to express your interest in presenting at the Ophthalmology Tech Forum 2024. Our Capital & Growth team will review and connect with you to discuss presentation opportunities.

Future Focused: Innovations and Entrepreneurship

We are bringing together the best and brightest in the industry to discuss the latest trends and advancements in ophthalmology. We will be covering topics like State of the Ophthalmic Industry Report, Disruptive Innovations, The Investment Landscape, and a Fireside Chat with Brent Saunders, Chairman and CEO, Bausch & Lomb.

Ophthalmology Tech Forum 2024

Newport Beach Marriott Hotel & Spa 900 Newport Center Drive, Newport Beach, CA, United States

At Ophthalmology Tech Forum, industry, key opinion leaders, and top ophthalmologists discuss the future of the industry. The event is held annually in Orange County, the center for Ophthalmology in […]

Women Leaders of Octane Quarterly Meeting (July 2024)


Please join Women Leaders of Octane for our virtual quarterly meeting, Wednesday, July 17 from 12 – 1 pm PST, featuring our Spotlight Thought Leader, Paige Hendrix Buckner, CEO of […]

Contact Us.


4041 MacArthur Blvd, Suite 260 Newport Beach, CA 92660


© 2024 Octane